Aoki H. Changes over time in treatment for obstructive jaundice. World J Gastrointest Surg 2024; 16(10): 3074-3077 [PMID: 39575272 DOI: 10.4240/wjgs.v16.i10.3074]
Corresponding Author of This Article
Hideki Aoki, PhD, Chief Physician, Department of Surgery, National Hospital Organization Iwakuni Clinical Center, 1-1-1 Atago, Iwakuni 740-8510, Yamaguchi, Japan. xxaoki@gmail.com
Research Domain of This Article
Surgery
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Surg. Oct 27, 2024; 16(10): 3074-3077 Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3074
Changes over time in treatment for obstructive jaundice
Hideki Aoki
Hideki Aoki, Department of Surgery, National Hospital Organization Iwakuni Clinical Center, Iwakuni 740-8510, Yamaguchi, Japan
Author contributions: Aoki H is the sole author of this manuscript and contributed to every process of this article.
Conflict-of-interest statement: The authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Hideki Aoki, PhD, Chief Physician, Department of Surgery, National Hospital Organization Iwakuni Clinical Center, 1-1-1 Atago, Iwakuni 740-8510, Yamaguchi, Japan. xxaoki@gmail.com
Received: March 5, 2024 Revised: June 24, 2024 Accepted: July 15, 2024 Published online: October 27, 2024 Processing time: 207 Days and 3.1 Hours
Abstract
This editorial discusses an article by Peng et al. This study reviewed the efficacy and safety of a new approach for treating obstructive jaundice. Although the pathophysiology of obstructive jaundice has not yet been fully elucidated, progress has been made in its management. There are two aspects of obstructive jaundice: Cholestatic status and absence of bile in the intestinal lumen. Internal biliary drainage resolved both the conditions. Clinically, endoscopic retrograde biliary drainage (ERBD) has replaced percutaneous transhepatic biliary drainage, and ERBD is transitioning to endoscopic ultrasound guided biliary drainage. This editorial briefly explains the mechanism and treatment of obstructive jaundice and the prospects of this new internal biliary drainage technique.
Core Tip: Internal drainage is considered ideal for biliary drainage; endoscopic retrograde biliary drainage (ERBD) has replaced percutaneous transhepatic biliary drainage, and ERBD is transitioning to endoscopic ultrasound guided biliary drainage. This editorial describes longitudinal studies on obstructive jaundice and the prospects for new internal biliary drainage.
